Literature DB >> 20090564

Hydrogen sulfide does not increase resuscitability in a porcine model of prolonged cardiac arrest.

Matthias Derwall1, Maren Westerkamp, Céline Löwer, Jan Deike-Glindemann, Nora Katharina Schnorrenberger, Mark Coburn, Kay Wilhelm Nolte, Nadine Gaisa, Joachim Weis, Katharina Siepmann, Martin Häusler, Rolf Rossaint, Michael Fries.   

Abstract

Treatment options to improve resuscitability and neurological prognosis after cardiac arrest (CA) are limited. Hydrogen sulfide has demonstrated remarkable improvements in outcomes in small animal models of severe hypoxia or hemorrhage. We investigated the influence of sodium sulfide (Na2S), a liquid hydrogen sulfide donor, on resuscitability, postresuscitation hemodynamics, and neurological performance in a porcine model of prolonged CA and cardiopulmonary resuscitation. Twenty-four male pigs were instrumented with arterial and pulmonary artery catheters before 10 min of CA was induced. During resuscitation, animals were randomized to receive either high-dose (1 mg/kg; n = 8) or low-dose (0.3 mg/kg; n = 8) Na2S (IK-1001; Ikaria, Clinton, NJ) or control (saline placebo; n = 8) i.v. injection and consecutive infusion. Cardiopulmonary resuscitation was performed for 6 min before defibrillation was attempted. Hemodynamic variables were taken at baseline and 10, 30, 60, 120, and 240 min after successful resuscitation. Neurological outcome was evaluated on 4 postoperative days before brains and hearts were harvested for histopathologic analysis. No differences in hemodynamic parameters were observed at baseline. Initial resuscitability was not improved by Na2S. Animals exposed to high- and low-dose Na2S showed significantly reduced cardiac output, heart rate, and pulmonary arterial pressure compared with control animals during the early postresuscitation period. Strikingly, two of the high-dose Na2S animals died during the postresuscitation period, whereas all other animals survived. High-dose Na2S significantly decreased microglial activation in striatal areas, although this did not translate into improved neurological outcome. Although animals receiving Na2S developed higher troponin T serum levels, these differences remained insignificant. In this investigation, Na2S did not improve resuscitability but significantly compromised postresuscitation hemodynamics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20090564     DOI: 10.1097/SHK.0b013e3181d0ee3d

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  13 in total

Review 1.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.

Authors:  Katalin Módis; Eelke M Bos; Enrico Calzia; Harry van Goor; Ciro Coletta; Andreas Papapetropoulos; Mark R Hellmich; Peter Radermacher; Frédéric Bouillaud; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 2.  H2S during circulatory shock: some unresolved questions.

Authors:  Oscar McCook; Peter Radermacher; Chiara Volani; Pierre Asfar; Anita Ignatius; Julia Kemmler; Peter Möller; Csaba Szabó; Matthew Whiteman; Mark E Wood; Rui Wang; Michael Georgieff; Ulrich Wachter
Journal:  Nitric Oxide       Date:  2014-03-18       Impact factor: 4.427

3.  Sodium sulfide prevents water diffusion abnormality in the brain and improves long term outcome after cardiac arrest in mice.

Authors:  Kotaro Kida; Shizuka Minamishima; Huifang Wang; JiaQian Ren; Kazim Yigitkanli; Ala Nozari; Joseph B Mandeville; Philip K Liu; Christina H Liu; Fumito Ichinose
Journal:  Resuscitation       Date:  2012-02-25       Impact factor: 5.262

4.  Hydrogen sulfide improves neural function in rats following cardiopulmonary resuscitation.

Authors:  Ji-Yan Lin; Min-Wei Zhang; Jin-Gao Wang; Hui Li; Hong-Yan Wei; Rong Liu; Gang Dai; Xiao-Xing Liao
Journal:  Exp Ther Med       Date:  2015-12-16       Impact factor: 2.447

5.  Mitochondria-targeted hydrogen sulfide donor AP39 improves neurological outcomes after cardiac arrest in mice.

Authors:  Kohei Ikeda; Eizo Marutani; Shuichi Hirai; Mark E Wood; Matthew Whiteman; Fumito Ichinose
Journal:  Nitric Oxide       Date:  2015-05-07       Impact factor: 4.427

6.  Life or death? A physiogenomic approach to understand individual variation in responses to hemorrhagic shock.

Authors:  Harold G Klemcke; Bina Joe; Rajiv Rose; Kathy L Ryan
Journal:  Curr Genomics       Date:  2011-09       Impact factor: 2.236

7.  Doubling survival and improving clinical outcomes using a left ventricular assist device instead of chest compressions for resuscitation after prolonged cardiac arrest: a large animal study.

Authors:  Matthias Derwall; Anne Brücken; Christian Bleilevens; Andreas Ebeling; Philipp Föhr; Rolf Rossaint; Karl B Kern; Christoph Nix; Michael Fries
Journal:  Crit Care       Date:  2015-03-26       Impact factor: 9.097

Review 8.  Is pharmacological, H₂S-induced 'suspended animation' feasible in the ICU?

Authors:  Pierre Asfar; Enrico Calzia; Peter Radermacher
Journal:  Crit Care       Date:  2014-03-18       Impact factor: 9.097

Review 9.  A systematic review of neuroprotective strategies after cardiac arrest: from bench to bedside (part II-comprehensive protection).

Authors:  Lei Huang; Patricia M Applegate; Jason W Gatling; Dustin B Mangus; John Zhang; Richard L Applegate
Journal:  Med Gas Res       Date:  2014-05-20

Review 10.  Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia.

Authors:  Eelke M Bos; Harry van Goor; Jaap A Joles; Matthew Whiteman; Henri G D Leuvenink
Journal:  Br J Pharmacol       Date:  2015-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.